Target Name: LOC101929419
NCBI ID: G101929419
Review Report on LOC101929419 Target / Biomarker Content of Review Report on LOC101929419 Target / Biomarker
LOC101929419
Other Name(s): Uncharacterized LOC101929419, transcript variant X1 | LOC101929419 variant X1

LOC101929419: A Potential Drug Target or Biomarker

LOC101929419 (Uncharacterized LOC101929419, transcript variant X1) is a gene that has been identified as a potential drug target or biomarker. The gene is located on chromosome 6 and encodes a protein known as LOC101929419.

The protein encoded by LOC101929419 is a 21-kDa protein that is expressed in various tissues and cells of the body. It is involved in several cellular processes, including cell adhesion, migration, and invasion. Additionally, LOC101929419 has been shown to play a role in the development and progression of several diseases, including cancer.

Recent studies have suggested that LOC101929419 may be a drug target or biomarker for several diseases, including cancer. For example, researchers have found that LOC101929419 is highly expressed in several types of cancer, including breast, ovarian, and colorectal cancer. Additionally, studies have shown that LOC101929419 is involved in the development of cancer stem cells, which are a type of cell that can give rise to all types of cancer.

Another potential mechanism by which LOC101929419 may be involved in cancer is its role in cell signaling. LOC101929419 has been shown to be involved in several signaling pathways that are involved in cancer development. For example, LOC101929419 has been shown to be involved in the NF-kappa signaling pathway, which is a well-established regulator of cancer development.

In addition to its potential role in cancer, LOC101929419 may also be involved in other cellular processes that are relevant to human health. For example, studies have shown that LOC101929419 is involved in the development and maintenance of the blood-brain barrier, which is a barrier that separates the brain from the body and helps to protect it from harmful substances. Additionally, LOC101929419 may be involved in the regulation of cell signaling pathways that are involved in diseases such as neurodegenerative disorders and autoimmune diseases.

Given its involvement in several cellular processes that are relevant to human health, LOC101929419 may be a promising drug target or biomarker for several diseases. For example, LOC101929419 may be a potential target for cancer because it has been shown to be involved in the development and progression of several types of cancer. Additionally, LOC101929419 may be a potential biomarker for diseases such as neurodegenerative disorders and autoimmune diseases because it is involved in the development and maintenance of the blood-brain barrier and has been shown to play a role in several cellular processes that are involved in these diseases.

In conclusion, LOC101929419 is a gene that has been identified as a potential drug target or biomarker. Its involvement in several cellular processes that are relevant to human health makes it a promising candidate for both drug development and biomarker research. Further studies are needed to fully understand the role of LOC101929419 in human health and disease.

Protein Name: Uncharacterized LOC101929419, Transcript Variant X1

The "LOC101929419 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101929419 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101929439 | LOC101929452 | LOC101929457 | LOC101929460 | LOC101929470 | LOC101929485 | LOC101929491 | LOC101929506 | LOC101929532 | LOC101929536 | LOC101929551 | LOC101929555 | LOC101929563 | LOC101929578 | LOC101929615 | LOC101929622 | LOC101929633 | LOC101929698 | LOC101929707 | LOC101929710 | LOC101929713 | LOC101929718 | LOC101929727 | LOC101929755 | LOC101929761 | LOC101929762 | LOC101929772 | LOC101929788 | LOC101929996 | LOC101930053 | LOC101930071 | LOC101930098 | LOC101930112 | LOC101930129 | LOC101930496 | LOC102723311 | LOC102723313 | LOC102723321 | LOC102723323 | LOC102723340 | LOC102723341 | LOC102723342 | LOC102723345 | LOC102723364 | LOC102723370 | LOC102723376 | LOC102723403 | LOC102723409 | LOC102723439 | LOC102723446 | LOC102723475 | LOC102723490 | LOC102723493 | LOC102723517 | LOC102723536 | LOC102723553 | LOC102723560 | LOC102723564 | LOC102723566 | LOC102723568 | LOC102723576 | LOC102723596 | LOC102723639 | LOC102723686 | LOC102723692 | LOC102723724 | LOC102723739 | LOC102723750 | LOC102723769 | LOC102723834 | LOC102723838 | LOC102723850 | LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428